163 related articles for article (PubMed ID: 32093313)
1. TLR3 Expression Induces Apoptosis in Human Non-Small-Cell Lung Cancer.
Bianchi F; Alexiadis S; Camisaschi C; Truini M; Centonze G; Milione M; Balsari A; Tagliabue E; Sfondrini L
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093313
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 3 as a new marker to detect high risk early stage Non-Small-Cell Lung Cancer patients.
Bianchi F; Milione M; Casalini P; Centonze G; Le Noci VM; Storti C; Alexiadis S; Truini M; Sozzi G; Pastorino U; Balsari A; Tagliabue E; Sfondrini L
Sci Rep; 2019 Oct; 9(1):14288. PubMed ID: 31582772
[TBL] [Abstract][Full Text] [Related]
3. Exploiting poly(I:C) to induce cancer cell apoptosis.
Bianchi F; Pretto S; Tagliabue E; Balsari A; Sfondrini L
Cancer Biol Ther; 2017 Oct; 18(10):747-756. PubMed ID: 28881163
[TBL] [Abstract][Full Text] [Related]
4. Detection of tumor antigens and tumor-antigen specific T cells in NSCLC patients: Correlation of the quality of T cell responses with NSCLC subtype.
Palata O; Podzimkova Hradilova N; Mysiková D; Kutna B; Mrazkova H; Lischke R; Spisek R; Adkins I
Immunol Lett; 2020 Mar; 219():46-53. PubMed ID: 31931024
[TBL] [Abstract][Full Text] [Related]
5. Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer.
Theelen WSME; Kuilman T; Schulze K; Zou W; Krijgsman O; Peters DDGC; Cornelissen S; Monkhorst K; Sarma P; Sumiyoshi T; Amler LC; Willems SM; Blaauwgeers JLG; van Noesel CJM; Peeper DS; van den Heuvel MM; Kowanetz M
PLoS One; 2019; 14(5):e0216864. PubMed ID: 31125352
[TBL] [Abstract][Full Text] [Related]
6. Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis.
Samara KD; Antoniou KM; Karagiannis K; Margaritopoulos G; Lasithiotaki I; Koutala E; Siafakas NM
Int J Oncol; 2012 May; 40(5):1397-404. PubMed ID: 22344343
[TBL] [Abstract][Full Text] [Related]
7. Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway.
Jiang Q; Wei H; Tian Z
BMC Cancer; 2008 Jan; 8():12. PubMed ID: 18199340
[TBL] [Abstract][Full Text] [Related]
8. Release of c-FLIP brake selectively sensitizes human cancer cells to TLR3-mediated apoptosis.
Alkurdi L; Virard F; Vanbervliet B; Weber K; Toscano F; Bonnin M; Le Stang N; Lantuejoul S; Micheau O; Renno T; Lebecque S; Estornes Y
Cell Death Dis; 2018 Aug; 9(9):874. PubMed ID: 30158588
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-35 Suppresses the Antitumor Activity of T Cells in Patients with Non-Small Cell Lung Cancer.
Wang HM; Zhang XH; Feng MM; Qiao YJ; Ye LQ; Chen J; Fan FF; Guo LL
Cell Physiol Biochem; 2018; 47(6):2407-2419. PubMed ID: 29991058
[TBL] [Abstract][Full Text] [Related]
10. Programmed cell death ligand-1 (PD-L1) expression combined with CD8 tumor infiltrating lymphocytes density in non-small cell lung cancer patients.
El-Guindy DM; Helal DS; Sabry NM; Abo El-Nasr M
J Egypt Natl Canc Inst; 2018 Dec; 30(4):125-131. PubMed ID: 30337185
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 3 agonist poly I:C reinforces the potency of cytotoxic chemotherapy via the TLR3-UNC93B1-IFN-β signaling axis in paclitaxel-resistant colon cancer.
Zhao J; Xue Y; Pan Y; Yao A; Wang G; Li D; Wang T; Zhao S; Hou Y
J Cell Physiol; 2019 May; 234(5):7051-7061. PubMed ID: 30387134
[TBL] [Abstract][Full Text] [Related]
12. Immune Microenvironment Differences Between Squamous and Non-squamous Non-small-cell Lung Cancer and Their Influence on the Prognosis.
Meng X; Gao Y; Yang L; Jing H; Teng F; Huang Z; Xing L
Clin Lung Cancer; 2019 Jan; 20(1):48-58. PubMed ID: 30341017
[TBL] [Abstract][Full Text] [Related]
13. The immune microenvironment in non-small cell lung cancer is predictive of prognosis after surgery.
Öjlert ÅK; Halvorsen AR; Nebdal D; Lund-Iversen M; Solberg S; Brustugun OT; Lingjaerde OC; Helland Å
Mol Oncol; 2019 May; 13(5):1166-1179. PubMed ID: 30854794
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus type 16 E6 oncoprotein promotes proliferation and invasion of non-small cell lung cancer cells through Toll-like receptor 3 signaling pathway.
Wang X; Zhang Z; Cao H; Niu W; Li M; Xi X; Wang J
J Med Virol; 2017 Oct; 89(10):1852-1860. PubMed ID: 28480962
[TBL] [Abstract][Full Text] [Related]
15. Expression of TRAG-3 antigen in non-small-cell lung carcinomas.
Chen Z; Zhu B; Wu Y
Lung Cancer; 2002 Oct; 38(1):101-2. PubMed ID: 12367802
[No Abstract] [Full Text] [Related]
16. CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients.
Djenidi F; Adam J; Goubar A; Durgeau A; Meurice G; de Montpréville V; Validire P; Besse B; Mami-Chouaib F
J Immunol; 2015 Apr; 194(7):3475-86. PubMed ID: 25725111
[TBL] [Abstract][Full Text] [Related]
17. The exploitation of Toll-like receptor 3 signaling in cancer therapy.
Glavan TM; Pavelic J
Curr Pharm Des; 2014; 20(42):6555-64. PubMed ID: 25341932
[TBL] [Abstract][Full Text] [Related]
18. Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.
Kinoshita T; Kudo-Saito C; Muramatsu R; Fujita T; Saito M; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Hayashi Y; Kaseda K; Kamiyama I; Ohtsuka T; Tomizawa K; Shimoji M; Mitsudomi T; Asamura H; Kawakami Y
Eur J Cancer; 2017 Nov; 86():15-27. PubMed ID: 28950145
[TBL] [Abstract][Full Text] [Related]
19. Non-small Cell Lung Cancer Cells Modulate the Development of Human CD1c
Lu Y; Xu W; Gu Y; Chang X; Wei G; Rong Z; Qin L; Chen X; Zhou F
Front Immunol; 2019; 10():2829. PubMed ID: 31921114
[TBL] [Abstract][Full Text] [Related]
20. Expression of MAGE-D4, a novel MAGE family antigen, is correlated with tumor-cell proliferation of non-small cell lung cancer.
Ito S; Kawano Y; Katakura H; Takenaka K; Adachi M; Sasaki M; Shimizu K; Ikenaka K; Wada H; Tanaka F
Lung Cancer; 2006 Jan; 51(1):79-88. PubMed ID: 16225959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
